Bengaluru: Leucine Rich Bio, South Asia’s first and only dedicated microbiome company, has announced a strategic partnership with Micro Health Labs, a premier diagnostics provider in Qatar, to launch BugSpeaks®, its flagship gut microbiome test, in the Qatari market. This move reinforces Leucine Rich Bio’s mission to make microbiome-based preventive healthcare accessible across the globe.
BugSpeaks, South Asia’s first and clinically tested microbiome test, is currently empowering consumers and clinicians in the UAE, Brazil, Malaysia, Thailand, Philippines, and now Qatar. With this partnership, residents of Qatar will now have access to cutting-edge gut health diagnostics that decode the hidden microbial world within, enabling smarter, preventive, and personalised healthcare.
BugSpeaks® is more than a test—it’s a revolutionary tool that uncovers the state of your gut microbiota and connects it to a broad spectrum of health indicators including metabolism, immunity, mental health, skin conditions, lifestyle disorders, and more. Developed using proprietary algorithms and curated microbiome and other proprietary databases, BugSpeaks® delivers clinically relevant reports with dietary, probiotic, and lifestyle recommendations.
BugSpeaks® stands out in the world of gut microbiome testing with several unique strengths. It offers personalised recommendations that are tailored to an individual’s microbiome profile, enabling more precise lifestyle and dietary guidance. The test is non-invasive, requiring only a simple stool sample that can be collected easily at home, making it highly user-friendly. Backed by robust scientific research, it delivers evidence-based insights across multiple health dimensions, including immunity, metabolism, mental health, and lifestyle disorders. BugSpeaks® is trusted and used by a diverse global network of doctors, nutritionists, fitness experts, wellness centres, and hospitals, reflecting its clinical reliability and versatility. Importantly, Leucine Rich Bio is the only ISO-certified and NABH accredited organization in this domain in India, adhering to stringent quality and clinical standards to ensure accurate and actionable results.
With Micro Health Labs’ established footprint across Qatar and a reputation for quality diagnostics, the partnership ensures that BugSpeaks® is delivered with local clinical expertise and trust.
Dr. Debojyoti Dhar, Co-Founder and Director, at Leucine Rich Bio (BugSpeaks), said, “At Leucine Rich Bio, we believe that gut health is foundational to every aspect of human well-being. Our partnership with Micro Health Labs marks a crucial step in bringing this science to the forefront of healthcare in Qatar. Together, we are committed to enabling early detection, better disease prevention, and a shift towards truly personalised medicine.”
This strategic alliance is part of Leucine Rich Bio’s global expansion initiative, aiming to democratise access to microbiome testing and position gut health as a key pillar in preventive healthcare systems across the world.
With growing demand for functional health insights and personalised diagnostics in the Middle East, this partnership is set to empower individuals in Qatar with data-driven tools for proactive wellbeing.
